Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer (vol 15, pg 791, 2020)

被引：0
|
作者：
Scott, Lesley J. [1 ]
机构：
[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
来源：
TARGETED ONCOLOGY | 2022年 / 17卷 / 03期
关键词：
D O I：
10.1007/s11523-022-00885-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The article “Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer.
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [1] Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2020, 15 (06) : 791 - 799
  • [2] Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Targeted Oncology, 2020, 15 : 791 - 799
  • [3] Darolutamide for non-metastatic, castration-resistant prostate cancer
    Burki, Talha
    LANCET ONCOLOGY, 2019, 20 (03): : E139 - E139
  • [4] Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Targeted Oncology, 2022, 17 : 381 - 381
  • [5] Darolutamide for non-metastatic castration- resistant prostate cancer
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (04) : 293 - 295
  • [6] Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Al-Salama, Zaina T.
    DRUGS, 2019, 79 (14) : 1591 - 1598
  • [7] Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Zaina T. Al-Salama
    Drugs, 2019, 79 : 1591 - 1598
  • [8] Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use
    Yang, Cheng-Kuang
    Cha, Tai -Lung
    Chang, Yen-Hwa
    Huang, Shu-Pin
    Lin, Jen-Tai
    Wang, Shian-Shiang
    Huang, Chao-Yuan
    Pang, See-Tong
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (04) : 299 - 308
  • [9] Sequential therapy with darolutamide in patients with non-metastatic castration-resistant prostate cancer resistant to enzalutamide or apalutamide
    Fujmoto, Saizo
    Fujita, Kazutoshi
    Nishimoto, Mitsuhisa
    Hamaguchi, Mamoru
    Kuwahara, Ken
    Hashimoto, Mamoru
    Adomi, Shogo
    Minami, Takafumi
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    CANCER MEDICINE, 2023, 12 (03): : 3176 - 3179
  • [10] Efficacy and safety of darolutamide in non-metastatic castration-resistant prostate cancer (nmCRPC) in the ARAMIS trial
    Pang, J. S-T.
    Shore, N.
    Smith, M. R.
    Tammela, T. L.
    Ulys, A.
    Vjaters, E.
    Polyakov, S.
    Jievaltas, M.
    Luz, M.
    Alekseev, B.
    Kuss, I.
    Le Berre, M-A.
    Snapir, A.
    Sarapohja, T.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2019, 30
12345